Skip to content

Flanigan's Enterprises BDL Sale of stock, price per share (in dollars per share)

Sale of stock, price per share (in dollars per share) at other companies

Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$0.01
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$60.00
electroCore, Inc. logo
electroCore, Inc.ECOR
$6.62
SKYX Platforms Corp. logo
SKYX Platforms Corp.SKYX
$1.20
CBAK Energy Technology, Inc. logo
CBAK Energy Technology, Inc.CBAT
$5.18
New America Acquisition I
 logo
New America Acquisition I NWAX
$10.00

Other financials

Income statement

See full
Revenue$56.5M+5.9%
Gross profit$48.0M+9.7%
Operating income$4.2M+18.6%
Net income$2.9M+6.9%
EPS (diluted)$1.55+6.9%

Balance sheet

See full
Cash & equivalents$22.8M-0.6%
Total debt$47.2M-3.0%
Total equity$68.8M+7.5%
Total assets$144.8M+1.0%

Cash flow

See full
Operating cash flow$2.1M
CapEx$881.0K-10.5%
Free cash flow$1.3M

Valuation

See full
Market cap$83.34M+24.2%
Enterprise value$107.68M+11.3%
P/E14×-1.6×
P/S0.4×+0.1×

Profitability

See full
Gross margin97.3%+0.1pp
Operating margin4.9%+1.4pp
Net margin2.8%+0.8pp
FCF margin4.1%

Returns & leverage

See full
Return on equity9%+2.5pp
Debt / equity0.7×-0.1×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by Flanigan's Enterprises in its filing.

Tagged under the XBRL concept us-gaap:SaleOfStockPricePerShare.

The official record: Flanigan's Enterprises’s 10-K, filed December 19, 2025, on SEC EDGAR. View the filing →

Ask your AI about Flanigan's Enterprises's sale of stock, price per share (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Flanigan's Enterprises's sale of stock, price per share (in dollars per share)?
Flanigan's Enterprises (BDL) reported sale of stock, price per share (in dollars per share) of $15.00 in Q3 2025.
What does sale of stock, price per share (in dollars per share) mean?
The average price per share received by the company during equity issuance activities. This metric reflects the market's valuation of the company's equity at the time of capital raising. It is a key indicator of investor sentiment and the cost of equity financing.